FDA panel endorses Novavax Covid-19 shot

Rise and shine, everybody, one other busy day is on the way in which. Sure, certainly, the center of the week is already right here, which implies there may be a lot to do. Little doubt, you possibly can relate on some degree. So please be a part of us as we seize a cup of stimulation — keep in mind, no prescription is required — and deal with the web calls and conferences and deadlines which might be piling up. In the meantime, right here is the most recent seize of things of curiosity that can assist you alongside. Hope you conquer the world as we speak, and do keep in contact. …

A U.S. Meals and Drug Administration knowledgeable panel voted overwhelmingly to suggest the company problem an emergency use authorization for the Novavax Covid-19 vaccine — a long-awaited win for a corporation that has struggled to succeed in this level, STAT writes. The Vaccines and Associated Organic Merchandise Advisory Committee voted 21-to-0 to suggest the vaccine obtain an EUA, with a single abstention. The robust vote belied the tenor of a lot of the dialogue, which began with one member of the committee, Eric Rubin, editor of the New England Journal of Drugs, questioning whether or not further EUAs are wanted when three vaccines are already in use within the nation.